Answers are grounded in this paper and cite their sources.
This policy-driven effort aims to improve treatment sequencing practices in multiple myeloma, suggesting coordinated strategies.
Uncertainty plays a central role in shaping sequencing practices in MM, underscoring the need for better evidence to guide decisions and avoid suboptimal use of treatment options. As the therapeutic landscape continues to expand, sequencing will be even more complex, which necessitates international coordinated efforts. The multi-stakeholder discussion presented here represents an initial step toward enabling such joint actions.
No takes yet. Share an insight, caveat, or question.
Pozsár et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: